This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Agency for Science, Technology and Research. Active years: 2014-2016.
Company Filing History:
Years Active: 2014-2016
Title: Innovations by Shengyong Ng in Bioactive Agent Delivery
Introduction
Shengyong Ng is a notable inventor based in Singapore, recognized for his contributions to the field of bioactive agent delivery systems. With a focus on developing innovative formulations, he has made significant strides in the medical and pharmaceutical industries. His work primarily revolves around the use of particulate hyaluronic acid and flavonoid formulations.
Latest Patents
Shengyong Ng holds 2 patents that showcase his innovative approach to cellular delivery of bioactive agents. His latest patents include formulations that utilize a suspension of immiscible particles, which comprise an agglomeration of a bioactive agent, such as an anti-cancer agent. These formulations also incorporate conjugates of hyaluronic acid and flavonoids, specifically catechin-based flavonoids. The particles in these suspensions range from about 15 nm to about 300 nm in diameter, allowing for effective delivery of the bioactive agent to cells, including cancer cells. The therapeutic formulations developed by Ng provide methods for using these suspensions to treat diseases, including cancer.
Career Highlights
Shengyong Ng is affiliated with the Agency for Science, Technology and Research, where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in improving treatment options for various diseases.
Collaborations
Ng has collaborated with esteemed colleagues, including Motoichi Kurisawa and Joo Eun Chung, to further enhance the impact of his research in the field of bioactive agent delivery.
Conclusion
Shengyong Ng's innovative work in the development of particulate hyaluronic acid and flavonoid formulations represents a significant advancement in the delivery of bioactive agents. His contributions are poised to make a meaningful impact in the treatment of diseases, particularly cancer.